Skip to main content
. 2022 Oct 17;75(Suppl 3):S459–S467. doi: 10.1093/cid/ciac533

Table 1.

Known Risk Factors for Poor Prognoses for Patients With Anthrax From Any Route of Infection as Noted in Reviewed References

Predictors for
Symptoms/Signs/Diagnostics Inhalation Anthrax Meningitis Severe Illness/Death
Symptoms
 Fever ± chills [11]
 Nausea/vomiting [15] [16] [17] [11]
 Sweats (diaphoresis) [15] [17]
 Headache [15] [11] [11]
 Headache, severe [11]
 Nonheadache, neurological symptoms [16]
 Cough [15] [19]
 Shortness of breath [15] [16] [19]
 Chest pain [15]
 Abdominal pain [15]
 Cyanosis/pallor [17]
Signs
 Bleeding (hematemesis) [11]
Vital signs
 Hypothermia [4]
 Tachycardia [18]
 Tachypnea [11]
 Systolic hypotension [4]
Skin/lesion description
 Large [4] [20] [21] [22] [23]
 Multiple [4] [20] [21] [22] [23]
 Including the head, neck, or upper torso [4] [20] [21] [22] [23]
 Surrounded by edema [4]
Neurologic
 Altered mental status [17] [11] [11]
 Meningeal signs [11]
 Nonheadache, nonmeningeal signsa [11]
Pulmonary
 Abnormal lung examination [16]
 Fulminant [11]
Diagnostic test results
 Bacteremia [2] [25]b
 Leukocytosis [4] [11]
 Hemoglobinemia [17] [18] [4]
 Thrombocytopenia [24]
 Hyponatremia [18] [4]
 Hypoalbuminemia [18] [4]
 Elevated transaminases [18] [4]
a

Nonheadache, nonmeningeal signs include seizure, cranial nerve signs, limb weakness, and papilledema.

b

Based on risk ratio calculation using data from Table 1 in Abramova et al [25].